Low blood counts: immune mediated, idiopathic, or myelodysplasia

Peter Valent1

  • 1Department of Internal Medicine I, Division of Hematology & Hemostaseology and Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria. peter.valent@meduniwien.ac.at

Insights

Diagnosing mild cytopenias can be challenging, especially in early myelodysplastic syndrome (MDS). This review outlines diagnostic approaches, highlighting circulating progenitor cells and flow cytometry as key indicators for unexplained cytopenias.

Area of Science:

  • Hematology
  • Clinical Diagnostics

Background:

  • Cytopenias are traditionally classified, but mild cases present diagnostic challenges.
  • Chronic mild cytopenias often have nonspecific laboratory and clinical signs, complicating diagnosis.
  • Distinguishing early myelodysplastic syndrome (MDS) from other causes of mild cytopenia is difficult.

Purpose of the Study:

  • To provide an overview of diagnostic approaches for patients with mild unexplained cytopenias.
  • To highlight key parameters for differentiating early MDS from other cytopenic conditions.
  • To offer diagnostic algorithms for challenging cytopenia cases.

Main Methods:

  • Review of diagnostic criteria and approaches for mild cytopenias.
  • Emphasis on peripheral blood parameters, specifically circulating colony-forming progenitor cells.
  • Inclusion of flow cytometric and molecular investigations for clonal vs. reactive conditions.

Main Results:

  • Circulating colony-forming progenitor cell numbers are a reliable peripheral blood parameter for early MDS detection.
  • Flow cytometry and molecular studies can aid in distinguishing clonal from reactive causes.
  • Traditional diagnostic criteria are often insufficient for mild or chronic cytopenias.

Conclusions:

  • Mild unexplained cytopenias require specialized diagnostic strategies beyond standard classifications.
  • Early identification of MDS in mild cytopenias is crucial and can be aided by progenitor cell counts.
  • Comprehensive diagnostic algorithms incorporating advanced techniques are essential for accurate diagnosis.

Related Concept Videos

Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.